<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03436277</url>
  </required_header>
  <id_info>
    <org_study_id>LC-CUT-DMHC</org_study_id>
    <nct_id>NCT03436277</nct_id>
  </id_info>
  <brief_title>Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training</brief_title>
  <official_title>Effect of the Administration of L-Carnitine on Body Fat Percentage and Body Weight in Overweight Women in Crossfit Training.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guadalajara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guadalajara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat
      degradation during exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blind, placebo-controlled clinical trial will be carry out in 24 woman
      with body mass index ≥ 25 to 29.9 kg/m2. The patients will receive 1.5 g of L-Carnitine
      deluded in 250 ml of water or placebo before crossfit training, 5 times a week for 8 weeks.
      Before and after intervention the investigators evaluate: The body composition (body fat,
      lean body mass), arm muscle circumference, waist circumference, body weight and body mass
      index.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 17, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Fat</measure>
    <time_frame>8 weeks</time_frame>
    <description>Calulated by Durnin formula. Results are reported in percentage and kg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lean body mass</measure>
    <time_frame>8 weeks</time_frame>
    <description>Calulated by Durnin formula. Results are reported in percentage and kg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Weight</measure>
    <time_frame>8 weeks</time_frame>
    <description>Subject go up onto the scale and stand still over the center of the scale with body weight evenly distributed between both feet. Omron hbf-514c an digital scale and results are reported in kg with a decimal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arm muscle circumference</measure>
    <time_frame>8 weeks</time_frame>
    <description>The right arm measure to the nearest centimeter with a measuring tape. Then, triceps skinfold thickness, an established measure of fat stores, measure to the nearest millimeter in the right arm using a skinfold caliper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>8 weeks</time_frame>
    <description>Flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.
Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.
Waist circumference was measured with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>8 weeks</time_frame>
    <description>Body mass divided by the square of the body height, and reported in units of kg/m2.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Body Weight Changes</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sucralose 1,5 g</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-Carnitine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>L- Carnitine 1,5 g</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-Carnitine</intervention_name>
    <description>L-Carnitine oral solution 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks</description>
    <arm_group_label>L-Carnitine</arm_group_label>
    <other_name>Levocarnitine</other_name>
    <other_name>Vitamin BT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sucralose</intervention_name>
    <description>Sucralose 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Trichlorogalacto-sucrose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers who practice crossfit regularly (who have 3 months prior to the beginning
             of the study practicing crossfit).

          -  Volunteers with a body mass index equal to or greater than 25 Kg/m2.

          -  Volunteers who do not have allergies to L-Carnitine or any of its components.

          -  Informed consent signed

          -  Women with a recommendation of nutrition two weeks prior to the start of the study.

          -  Body weight stable the last 3 months.

        Exclusion Criteria:

          -  Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and
             allergies.

          -  Women with confirmed or suspected pregnancy.

          -  Women under lactation and/or puerperium.

          -  Hypersensibilility to L-Carnitine or Sucralose.

          -  Kown of renal, hepatic or thyroid deseased.

          -  Current or previous treatment diet (3 months before inclusion to the study).

          -  Current pharmacological treatment for loose body weight or 3 months before inclusion
             to the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana M Hernández</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Guadalajara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diana M Hernández, PhD</last_name>
    <phone>+521 3314856584</phone>
    <email>diana.hcorona@academicos.udg.mx</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tonatiuh González, PhD</last_name>
    <phone>+521 3314664863</phone>
    <email>drtonatiuhgh@live.com.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro Universitario de Tonalá</name>
      <address>
        <city>Tonalá</city>
        <state>Jalisco</state>
        <zip>45425</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Huang A, Owen K. Role of supplementary L-carnitine in exercise and exercise recovery. Med Sport Sci. 2012;59:135-42. doi: 10.1159/000341934. Epub 2012 Oct 15.</citation>
    <PMID>23075564</PMID>
  </reference>
  <reference>
    <citation>Villani RG, Gannon J, Self M, Rich PA. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 2000 Jun;10(2):199-207.</citation>
    <PMID>10861338</PMID>
  </reference>
  <reference>
    <citation>Hongu N, Sachan DS. Carnitine and choline supplementation with exercise alter carnitine profiles, biochemical markers of fat metabolism and serum leptin concentration in healthy women. J Nutr. 2003 Jan;133(1):84-9.</citation>
    <PMID>12514272</PMID>
  </reference>
  <reference>
    <citation>Broad EM, Maughan RJ, Galloway S DR. Effects of exercise intensity and altered substrate availability on cardiovascular and metabolic responses to exercise after oral carnitine supplementation in athletes. Int J Sport Nutr Exerc Metab. 2011 Oct;21(5):385-97. Epub 2011 Aug 3.</citation>
    <PMID>21813919</PMID>
  </reference>
  <reference>
    <citation>Behrend AM, Harding CO, Shoemaker JD, Matern D, Sahn DJ, Elliot DL, Gillingham MB. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab. 2012 Jan;105(1):110-5. doi: 10.1016/j.ymgme.2011.09.030. Epub 2011 Oct 1.</citation>
    <PMID>22030098</PMID>
  </reference>
  <reference>
    <citation>Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson DA, Deschenes MR, Maresh CM. Androgenic responses to resistance exercise: effects of feeding and L-carnitine. Med Sci Sports Exerc. 2006 Jul;38(7):1288-96. Erratum in: Med Sci Sports Exerc. 2006 Oct;38(10):1861.</citation>
    <PMID>16826026</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2018</study_first_submitted>
  <study_first_submitted_qc>February 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>February 18, 2018</last_update_submitted>
  <last_update_submitted_qc>February 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guadalajara</investigator_affiliation>
    <investigator_full_name>Diana Mercedes Hernández Corona</investigator_full_name>
    <investigator_title>PhD of Pharmacology</investigator_title>
  </responsible_party>
  <keyword>Overweight</keyword>
  <keyword>Obesity</keyword>
  <keyword>L-Carnitine</keyword>
  <keyword>Body weight</keyword>
  <keyword>Body fat percentage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Body Weight Changes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

